Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00931892 · ClinicalTrials.gov registry record · NA
Serum Markers in Gluten Challenge
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT00931892 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 21 participants.
The verdict
NCT00931892, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
1. The purpose of this research study is to evaluate non-invasive markers of celiac disease activity in subjects that are on a gluten-free diet, in remission from celiac disease who undergo gluten challenge. 2. The secondary aims of this protocol are to identify novel mediators important in the pathophysiology of celiac disease and to evaluate changes in metabolism with gluten exposure.
Interventions
- DIETARY_SUPPLEMENT Gluten
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00931892
The ClinicalTrials.gov registry entry for NCT00931892 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gluten is the first listed.
NCT00931892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00931892 about?
NCT00931892 is a clinical study titled "Serum Markers in Gluten Challenge". 1. The purpose of this research study is to evaluate non-invasive markers of celiac disease activity in subjects that are on a gluten-free diet, in remission from celiac disease who undergo gluten challenge. 2. The secondary aims of this protocol are to identify novel mediators important in the path...
What is the current status of trial NCT00931892?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2009-04. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00931892?
The interventions under investigation include: Gluten (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00931892?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.